
Warning as venomous insect imported from China invades 19 US states... is your hometown at risk?
Officials are sounding the alarm as venomous Asian needle ants are invading more parts of the US.
These insects, native to China, have a sting that can trigger severe allergic reactions, and in extreme cases, death.
This invasive species was first spotted in the US more than 90 years ago, but its population has recently surged and is now spreading up the East Coast, experts say.
They are now found in 19 states: Florida, Georgia, Alabama, Mississippi, Arkansas, Tennessee, the Carolinas, Kentucky, Virginia, Ohio, Pennsylvania, Maryland, Connecticut, Rhode Island, Massachusetts, New York, Wisconsin and Washington state.
The Asian needle ant is a small-to-medium-sized ant, with workers and queens measuring up to one fifth of an inch in length. They are shiny, dark brown to black, with the end of the antennae and the legs being a lighter orange-brown.
Their stings cause 'intense pain' at the site that 'comes and goes over the course of several hours,' but some people have also reported pain away from the sting site, according to the US Department of Agriculture (USDA).
Some people may also experience anaphylaxis — a potentially life-threatening allergic reaction — as a result of an Asian needle ant sting.
These ants prefer damp areas beneath stones or rotting logs, but have also been found in parks, lawns, potted plants, under wood piles and hiding in construction materials such as logs, bricks and pavers.
They have also been reported foraging inside homes and buildings and may pose a problem as residential invaders in the future.
'We are now considering it a medically important pest,' Dan Suiter, a professor of urban entomology at the University of Georgia, told Fox Weather.
'It gets a little bit more serious when the sting of an insect can be life-threatening to people who suffer anaphylaxis,' he added.
Last year, Suiter responded to three cases of anaphylaxis in Georgians who had been stung by an Asian needle ant.
Symptoms of anaphylaxis include skin rashes, low blood pressure, constriction of the airway, swelling of the tongue or throat, weak and rapid pulse, nausea, vomiting or diarrhea, dizziness or fainting, and psychological symptoms such as a sense of impending doom.
While cases of anaphylaxis have been reported in the US, the percentage of Americans who have experienced this extreme reaction remains unknown.
But people who are hypersensitive to other stinging insects, such as bees, red ants or mosquitoes, could be at greater risk of severe reaction to an Asian needle ant sting.
A study conducted in the native range of this ant — which spans China, Japan and Korea — showed that 2.1 percent of people stung exhibited anaphylaxis.
This species isn't known to be aggressive, but it will sting to defend themselves when frightened. Their stingers can pierce through clothing to reach skin.
Asian needle ants are most likely to appear inside homes during 'swarming' season — the period during which insects emerge from hibernation to begin mating — which typically begins in spring and lasts through August.
This species is highly adaptable, and can thrive in both warm and cool climates as well as urban or rural areas.
'This behavioral versatility is allowing the Asian needle ant to move into forests, rural areas, and urban environments at the same time,' explained biology PhD and science writer Mary Bates in a 2013 article for the American Association for the Advancement of Science.
'Because it can tolerate cooler temperatures, it could spread into a broad range of territory,' she wrote.
And indeed it has. The Asian needle ant has established a vast population in the US, and scientists expect it will continue to spread.
This not only poses a threat to human health, but to the environment as well.
Studies have shown that this invasive species is displacing native ant species, causing their abundance and diversity to decline in areas where Asian needle ants are established.
Some of these native ant species are critical seed dispersers, carrying seeds away from their mother plant and ensure proper dispersal of the plant species.
'Researchers have demonstrated substantial decreases in seed dispersal where Asian needle ants have invaded forest areas,' the USDA states.
'Thus, this invasive species could have dramatic, long-term negative effects on forest understory.'
Researchers are studying and developing strategies to control this booming ant population.
But 'unfortunately, as with many invasive species, it appears Asian needle ants are here to stay,' the USDA states.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
34 minutes ago
- The Independent
CVS under investigation for sending text messages to customers lobbying against proposed bill
Louisiana Attorney General Liz Murrill has launched an investigation into CVS, probing whether or not the company has been improperly using its customers' personal information to send text messages lobbying against a state law. She said she also plans to issue the company a cease-and-desist letter to halt the texts, according to ABC News. Lawmakers debating the failed bill at the center of the controversy shared images of CVS's texts during a hearing on Wednesday. 'Last minute legislation in Louisiana threatens to close your CVS Pharmacy — your medication cost may go up and your pharmacist may lose their job,' one text said, according to the Associated Press. The bill would have prohibited companies from owning both pharmacy benefit managers and drug stores. CVS owns retail pharmacies as well as CVS Caremark, which is one of the nation's top three pharmacy benefit managers, meaning the law would have directly affected its business. CVS Caremark and other pharmacy managers essentially act as middlemen by purchasing prescription drugs from manufacturers and determining the terms for how those drugs are distributed to customers. In 2024, the Federal Trade Commission issued a report saying that the managers "may be profiting by inflating drug costs and squeezing Main Street pharmacies." In Louisiana, CVS's text messages included links to a draft letter asking lawmakers to reject the legislation. 'The proposed legislation would take away my and other Louisiana patients' ability to get our medications shipped right to our homes,' the letter read. 'They would also ban the pharmacies that serve patients suffering from complex diseases requiring specialty pharmacy care to manage their life-threatening conditions like organ transplants or cancer. These vulnerable patients cannot afford any disruption to their care – the consequences would be dire.' State Representative Dixon McMakin said CVS was "lying" and using "scare tactics" to oppose the legislation. CVS reportedly sent "large numbers" of texts to state employees and their families to lobby against the legislation, according to Murrill in her statement. Amy Thibault, a spokesperson for CVS, told ABC News that the texts were sent out in response to a last-minute amendment to the bill on Wednesday without holding a public hearing about the change. 'We believe we have a responsibility to inform our customers of misguided legislation that seeks to shutter their trusted pharmacy, and we acted accordingly,' Thibault said in an email to the broadcaster. 'Our communication with our customers, patients and members of our community is consistent with law.' The bill failed to pass the state Senate, which decided not to take it up for the 2025 session.


Daily Mail
2 hours ago
- Daily Mail
Scientists pinpoint way to check if you're going to get early-onset colon cancer with up to 92% accuracy
A little-known at-home test can detect early-onset colon cancer before symptoms develop, increasing the chance of surviving a disease that is surging among young people. The fecal immunochemical test (FIT) costs $49 and screens a person's feces for flecks of blood, a warning sign of the cancer — as tumors cause bleeding. The test is FDA-approved and allows younger people a chance to screen for colon cancer before they reach the recommended age for a colonoscopy, 45 years. If blood is detected, a colonoscopy is performed, increasing the chances of catching colon cancer early when it is more treatable. And the American College of Surgeons says it is generally accurate, able to detect about 80 percent of all cases. If someone opts for the $600 FIT with DNA screening, which checks for abnormal changes in cells' DNA, accuracy rises to 92 percent. A colonoscopy is about 99 percent accurate at detecting all cancers. A recent study found people that use the FIT method between the ages of 40 to 49 years old are 39 percent less likely to die from colon cancer than their peers who wait to get the test until they are 50 years old or above. An increasing number of younger people are seeking screening, as the US experiences a surge in colon cancer among people under 50, with young patients today about twice as likely to be diagnosed with the disease than their grandparents. The rising rates are prompting some physicians to urge Americans to start getting screened for the disease before the age of 45 years, which is when US doctors recommend. For the test, which can be ordered online, customers are sent a package containing a collection tube. They are asked to collect a sample of their feces from the toilet bowl, place it in the tube and mail it to a lab. Results take about five days to come back. In the lab, scientists expose the feces to antibodies that can bind to human hemoglobin - a protein found in red blood cells. If they bind to an area of the feces, a positive test result is issued - and patients are advised to undertake further screening. In the FIT with DNA, scientists also analyze cells found in the stool for abnormal changes - which could indicate cancer. Patients over 45 years old who have an average risk — meaning no family history of the disease — may be recommended the test, which is free for the group under health insurance plans. But people can also buy the test, which is sold by labs like Everlywell for $49, or opt for other tests like Cologuard, which is priced at $121. While the test can be extremely helpful, doctors caution that about five to 10 percent of patients who get a positive result do not have colon cancer or advanced polyps. The number of false positives after a colonoscopy is below one percent. It is important to follow up with a doctor to discuss results. Patients undertaking the test are recommended to do it every year, as this can help to catch early-onset cancers which are typically slower growing. Among patients to have their cancer caught after using an at-home stool-based test is Christine Bronstein, who was diagnosed with the cancer at age 48. The Hawaii local exercises regularly, and avoids sugar and alcohol. But after seeing blood in her stool in 2021, she became concerned and ordered a stool-based test. After results came back positive, she rushed to see her doctor and was eventually approved for a colonoscopy - which led to a stage three colon cancer diagnosis with a two-inch tumor found in her rectum. Bronstein told TODAY: 'I'm very lucky that I did my test when I did. This thing really takes people down right in their prime... I think the problem why this is becoming the No.1 killer for younger people is because their symptoms get denied.' Colon cancer cases are surging among under-50s in the US in an uptick that has stunned researchers, with adults born in the 1980s having double the risk of suffering from the cancer compared to their parents. Among adults aged 25 to 29 years, colon cancer cancer rates have spiked 85 percent in two decades according to CDC data. At the same time, over the last 30 years cases have dropped among over-50s by 30 percent.


Daily Mail
2 hours ago
- Daily Mail
New map reveals all the iconic US cities and landmarks set to DISAPPEAR by 2050
A new interactive map is painting a grim picture for America's coastal cities, with many projected to be underwater by 2050. Climate Central, an independent organization of scientists, has been developing a new Coastal Risk Screening Tool to predict how sea level rise and coastal flooding will reshape the US each decade.